Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer

byOhio State University Medical CenterExperts say the only way to know if there are high levels of radon in your home is to test for it. Radon is the leading cause of lung cancer among non-smoke

Updated on: April 30,2024 0

Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer

byOhio State University Medical CenterExperts say the only way to know if there are high levels of radon in your home is to test for it. Radon is the leading cause of lung cancer among non-smoke

Updated on:April 30,2024 0

On the trail of missing genes and cancer clues

byLa Jolla Institute for ImmunologyThe image on the left shows an eight-cell blastomere developed from mouse embryonic stem cells with normal TET function. The image on the right shows the conse

Updated on: January 16,2024 16

On the trail of missing genes and cancer clues

byLa Jolla Institute for ImmunologyThe image on the left shows an eight-cell blastomere developed from mouse embryonic stem cells with normal TET function. The image on the right shows the conse

Updated on:January 16,2024 16

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on: March 30,2024 0

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on:March 30,2024 0

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on: July 05,2024 0

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on:July 05,2024 0

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

Updated on: April 09,2024 19

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

Updated on:April 09,2024 19

Researchers find an epigenetic key that unlocks common deadly cancers

by Katherine Fenz,Rockefeller UniversityLesions (in green) akin to basal cell carcinoma that were induced by SOX9 in the epidermis. Abnormal differentiation is shown in red, and blue marks cell

Updated on: February 18,2024 18

Researchers find an epigenetic key that unlocks common deadly cancers

by Katherine Fenz,Rockefeller UniversityLesions (in green) akin to basal cell carcinoma that were induced by SOX9 in the epidermis. Abnormal differentiation is shown in red, and blue marks cell

Updated on:February 18,2024 18

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Updated on: January 23,2024 11

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Updated on:January 23,2024 11

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024 17

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024 17

Study shows how liver cancer hijacks circadian clock machinery inside cells

by Keck School of Medicine of USCPictured is an artist's rendering of circadian clock proteins BMAL1 and CLOCK influencing hepatocellular carcinoma (HCC) cell proliferation. The study shows t

Updated on: January 29,2024 16

Study shows how liver cancer hijacks circadian clock machinery inside cells

by Keck School of Medicine of USCPictured is an artist's rendering of circadian clock proteins BMAL1 and CLOCK influencing hepatocellular carcinoma (HCC) cell proliferation. The study shows t

Updated on:January 29,2024 16

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on: January 13,2024 17

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on:January 13,2024 17

Study shines light on gut microbiome in colon cancer

by American Society for MicrobiologyMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaResearchers have identified a correlation between gut microbial com

Updated on: July 02,2024 3

Study shines light on gut microbiome in colon cancer

by American Society for MicrobiologyMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaResearchers have identified a correlation between gut microbial com

Updated on:July 02,2024 3

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024 19

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024 19